跳至主要内容
临床试验/NCT01544530
NCT01544530终止2 期

Feasibility of Mild-to-moderate Therapeutic Hypothermia as an In-vivo Organ Preservation Strategy in Brain-dead Donors

University of Pittsburgh1 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2012年3月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
终止
入组人数
4
试验地点
1
主要终点
Feasibility and safety

研究概览

简要总结

The purpose of this study is to assess the feasibility and safety of mild-to-moderate hypothermia as an in-vivo organ preservation strategy compared to normothermia in 60 brain-dead organ donors.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age greater than 18 years;pronounced dead as per hospital brain-death criteria
  • •Accepted by organ procurement organization for organ donation
  • •Subjects within 3 hours of brain death pronouncement

排除标准

  • •Consent cannot be obtained from authorized representative;mean arterial pressure < 60 mmHg and/ or more than 2 vasopressor and/or inotrope use
  • •Presence of 2nd or 3rd degree heart block
  • •Ongoing extracranial hemorrhage
  • •International normalized ratio > 3.0
  • •Donors with human-immunodeficiency virus infection
  • •Pregnancy

研究组 & 干预措施

Hypothermia (32-33 degree C)

Experimental

Following randomization, hypothermia will be induced by a combination of cold isotonic fluid and sustained until organ procurement by a central venous catheter

干预措施: Cold isotonic fluid and central venous hypothermia catheter (Other)

Normothermia (36.5 - 37.5 degree C)

No Intervention

Normothermia will be maintained until organ procurement as per current standard of care

结局指标

主要结局

Feasibility and safety

时间窗: From enrollment to organ procurement (average of 24 hours)

Brain-dead organ donors will be followed from study enrollment up to organ procurement for an average of 24 hours

次要结局

  • Malondialdehyde(Baseline, 6 hours, and at organ procurement (15-24 hrs))
  • Actual no. of organs transplanted(At the time of organ procurement)
  • Death receptor-5(Baseline, 6 hours, and at organ procurement (15-24 hrs))
  • Six-month hospital free survival in recipients(6 months)
  • Interleukin-6(Baseline, 6 hours, and at organ procurement (15-24 hrs))
  • Urinary isoprostanes(Baseline, 6 hours, and at organ procurement (15-24 hrs))
  • lactate(Baseline, 6 hours, and at organ procurement (15-24 hrs))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Raghavan Murugan

Associate Professor

University of Pittsburgh

研究点 (1)

Loading locations...

相似试验